VCC Pediatric Trials: HEMATOLOGICAL

Acute Lymphoblastic Leukemia (ALL)

Treatment of Late Isolated Extramedullary Relapse from Acute Lymphoblastic Leukemia (ALL) (Initial CR 1>/=18 Months)
Protocol #: AALL02P2
Primary Investigator: Alan Homans, M.D.
Contact: Erin Paulsen (802) 656-9913

Understanding the Role of Adherence and Ethnic Differences in Survival After Childhood ALL
Protocol #: AALL03N1
Primary Investigator: Alan Homans, M.D.
Contact: Erin Paulsen (802) 656-9913

Standard Risk B-precursor Acute Lymphoblastic Leukemia
Protocol #: AALL0331
Primary Investigator: Alan Homans, M.D.
Contact: Erin Paulsen (802) 656-9913

High Risk B-precursor Acute Lymphoblastic Leukemia
Protocol #: AALL0232
Primary Investigator: Alan Homans, M.D.
Contact: Erin Paulsen (802) 656-9913

Classification of Acute Lymphoblastic Leukemia
Protocol #: AALL03B1
Primary Investigator: Alan Homans, M.D.
Contact: Erin Paulsen (802) 656-9913

Hodgkin's Disease

A Phase III Study for the Treatment of Children and Adolescents with Newly Diagnosed Low Risk Hodgkin Disease
Protocol #: AHOD0431
Primary Investigator: Alan Homans, M.D.
Contact: Erin Paulsen (802) 656-9913

A Phase III Study of Dose-Intensive, Response-Based Chemotherapy and Radiation Therapy for Children and Adolescents with Newly Diagnosed Intermediate Risk Hodgkin Disease
Protocol #: AHOD0031
Primary Investigator: Alan Homans, M.D.
Contact: Erin Paulsen (802) 656-9913

Post-Transplant Lymphoproliferative Disease

A Phase II Study of the Combination of Cyclophosphamide, Prednisone and Rituximab (CPR) in Children, Adolescents and Young Adults with CD20 Positive Post-Transplant Lymphoproliferative Disease
Protocol #: ANHL0221
Primary Investigator: Alan Homans, M.D.
Contact: Erin Paulsen (802) 656-9913